menu
    • menu

    Company profile for Eleison Pharmaceuticals

    NEW Drugs in Dev: 2
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Eleison's mission is to acquire, develop, and commercialize clinical stage drug candidates for "orphan" cancers, providing new hope for patients with rare, life-threatening diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Eleison PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Overlook Center, 2nd Floor Princeton NJ 08540
    Telephone
    Telephone
    +215-554-3530
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://eleison-pharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/eleison-pharmaceuticals-inc-/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eleison to Partner China Oncology Focus an Affiliate of Lee’s for Glufosfamide
    Eleison to Partner China Oncology Focus an Affiliate of Lee’s for Glufosfamide

    21 Nov 2017

    // PRESS RELEASE

    http://www.eleison-pharma.com/cushy_uploads/news_32_4097612997.pdf

    PRESS RELEASE
    21 Nov 2017
    Share Share
    Eleison Announces Approval from CFDA to Expand Eleison’s PhIII Glufosfamide
    Eleison Announces Approval from CFDA to Expand Eleison’s PhIII Glufosfamide

    16 May 2016

    // PRESS RELEASE

    http://www.eleison-pharma.com/cushy_uploads/news_30_1180908512.pdf

    PRESS RELEASE
    16 May 2016
    Share Share
    Eleison Announces the Issuance of New Patents for Glufosfamide and ILC
    Eleison Announces the Issuance of New Patents for Glufosfamide and ILC

    11 Dec 2015

    // PRESS RELEASE

    http://www.eleison-pharma.com/cushy_uploads/news_29_2036342757.pdf

    PRESS RELEASE
    11 Dec 2015
    Share Share
    Eleison Announces Successful Completion of Stage 1 of its Phase II Trial of ILC
    Eleison Announces Successful Completion of Stage 1 of its Phase II Trial of ILC

    01 May 2015

    // PRESS RELEASE

    http://www.eleison-pharma.com/cushy_uploads/news_28_3003006718.pdf

    PRESS RELEASE
    01 May 2015
    Share Share
    Eleison Announces Agreement with FDA on a SPA for a Ph3 Glufosfamide
    Eleison Announces Agreement with FDA on a SPA for a Ph3 Glufosfamide

    26 May 2010

    // PRESS RELEASE

    http://www.eleison-pharma.com/cushy_uploads/news_5_2316371766.pdf

    PRESS RELEASE
    26 May 2010
    Share Share
    Threshold Pharmaceuticals Licenses Glufosfamide to Eleison Pharmaceuticals
    Threshold Pharmaceuticals Licenses Glufosfamide to Eleison Pharmaceuticals

    15 Oct 2009

    // PRESS RELEASE

    http://www.eleison-pharma.com/cushy_uploads/news_5_2684301897.pdf

    PRESS RELEASE
    15 Oct 2009
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search